FDA issued a Warning Letter to California Pharmacy & Compounding Center on 6/17/2015 as a result of this inspection.
483 California Pharmacy & Compounding Center Oct 2014

483 California Pharmacy & Compounding Center Oct 2014

Ademola Daramola FDA, Binh Nguyen FDA, Liming Zhang FDA$119.00 - Available Now

FDA investigators audited the California Pharmacy & Compounding Center - Newport Beach, CA, United States facility and issued 3 inspectional observations (via FDA 483) on 17 Oct 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 17 Oct 2014
  • Location: Newport Beach, United States
  • FEI: 3004600090
Add To Cart